About CH Lannion
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Hospital, Brest
4
LivaNova
2
MicroPort CRM
1
Clinical Trials at CH Lannion
During the past decade, CH Lannion conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers
2007-06-01
2011-12-01
Completed
1,440
Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)
2007-07-01
2017-01-01
Completed
104
Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin
2009-07-01
2011-07-01
Terminated
34
EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients
2010-03-01
2017-08-31
Completed
4,350
Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism.
2013-06-27
2018-05-29
Terminated
235
Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode
2012-04-01
2015-12-01
Completed
848
Six Years of Follow-up After Idiopathic Venous Throbmoembolism
2013-03-28
2023-11-01
Recruiting
748
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CH Lannion"
#1 collaborator was "Ministry of Health, France" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at CH Lannion
According to Clinical.Site data, the most researched conditions in "CH Lannion" are
"Atrial Arrhythmia" (1 trials), "Atrioventricular Block" (1 trials), "HTPPE" (1 trials), "Idiopathic Deep Vein Thrombosis" (1 trials) and "Idiopathic Pulmonary Embolism" (1 trials). Many other conditions were trialed in "CH Lannion" in a lesser frequency.
Clinical Trials Intervention Types at CH Lannion
Most popular intervention types in "CH Lannion" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (1 trials), "HTPPE" (1 trials), "dual chamber pacemaker with SafeR algorithm" (1 trials), "placebo" (1 trials) and "placebo of warfarin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CH Lannion
The vast majority of trials in "CH Lannion" are
7 trials for "All" genders.
Clinical Trials Status at CH Lannion
Currently, there are NaN active trials in "CH Lannion".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in CH Lannion,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in CH Lannion, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".